首页> 外文期刊>Clinical nuclear medicine >13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
【24h】

13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.

机译:13N-NH3对颅内脑膜瘤检测中的F-18 FDG:初次报告。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Relatively high Tl-201 uptakes have been reported in all types of meningiomas, and it have been proposed that (201)TlCl SPECT could predict histologic types of meningiomas and differentiate the benign and aggressive meningiomas. Similar to Tl-201, (13)N-(13)NH(4)(+) is an analog of K(+) and could substitute K(+) in some cases. The aim of this study was to evaluate the capacity of PET with (13)N-NH(3) to discriminate meningioma from healthy tissue, and compare with F-18 FDG. METHODS: Eleven patients with the neuroradiologic diagnosis of meningiomas were studied with (13)N-NH(3), and 10 of them were performed with F-18 FDG PET within 3 days. Ten of them were histologically confirmed (6 grade I, 4 grade II), and another one was proved by radiologic (computed tomography and magnetic resonance imaging) and clinical investigation.The PET images were evaluated by semiquantitative analysis using tumor-to-white matter ratio (T/W). RESULTS: (13)N-NH(3) uptake was obviously increased in all 11 meningiomas with a good contrast to the surrounding normal brain tissues. Conversely, F-18 FDG uptake was decreased in comparison with the contralateral side in all 7 patients with grade I meningiomas and moderately increased in the remaining patient with grade II meningioma. The T/W ratio of (13)N-NH(3) was higher than that of F-18 FDG (7.03 +/- 1.62 vs. 1.44 +/- 0.57, P < 0.005). T/W of (13)N-NH(3) uptake was not useful for differentiating benign (Grade I) from atypical (Grade II) meningiomas (P = 0.88), whereas the T/W ratio of F-18 FDG uptake was better than that of N-NH3 for differentiating benign from malignant meningiomas (P = 0.037). CONCLUSIONS: These preliminary results suggest that (13)N-NH(3) has relatively greater uptake in meningiomas in comparison with F-18 FDG. Clinical applications of (13)N-NH(3) PET for grading and follow-up of meningiomas need to be assessed in further studies.
机译:目的:在各种类型的脑膜瘤中报道了相对高的TL-201上唇,已经提出(201)TLCL SPECT可以预测组织学类型的脑膜瘤并区分良性和侵略性的脑膜瘤。类似于TL-201,(13)N-(13)NH(4)(+)是K(+)的类似物,可以在某些情况下替代K(+)。本研究的目的是评估PET的能力(13)N-NH(3),以区分脑膜瘤免受健康组织,并与F-18 FDG进行比较。方法:使用(13)N-NH(3)进行脑膜瘤神经理诊断的11例,在3天内使用F-18 FDG PET进行其中10个。其中十个是组织学证实(I级,4级等级),并且通过放射学(计算机断层扫描和磁共振成像)和临床研究证明了另一种。通过使用肿瘤与白物的半定量分析评估PET图像比率(t / w)。结果:(13)N-NH(3)在所有11个脑膜瘤中摄取明显增加,与周围的正常脑组织良好的对比。相反,与II级脑膜血管瘤的剩余患者中所有7名患者中的对侧患者相比,F-18 FDG摄取量减少。 (13)N-NH(3)的T / W比率高于F-18 FDG(7.03 +/- 1.62与1.44 +/- 0.57,P <0.005)。 (13)N-NH(3)摄取不适用于区分非典型(II级)脑膜瘤(P = 0.88),而F-18 FDG摄取的T / W比率优于N-NH3,用于区分恶性脑膜瘤的良性(P = 0.037)。结论:这些初步结果表明(13)N-NH(3)与F-18 FDG相比,脑膜瘤的摄取相对较大。 (13)N-NH(3)宠物进行分级和后续的临床应用需要在进一步的研究中进行评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号